[1] Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients. Fang Zhang, Rixin Zhang, Jinbao Zong, Yufang Hou, Mingxuan Zhou, Zheng Yan, Tiegang Li, Wenqiang Gan, Silin Lv, Liu Yang, Zifan Zeng, Wenyi Zhao, Min Yang*. Frontiers in Immunology. 2023. (IF:7.3)
[2] Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer. Rixin Zhang, Wenqiang Gan, Jinbao Zong, Yufang Hou, Mingxuan Zhou, Zheng Yan, Tiegang Li, Silin Lv, Zifan Zeng, Weiqi Wang, Fang Zhang, Min Yang*. Frontiers in Immunology. 2023. (IF:7.3)
[3] Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer. Mingxuan Zhou, Silin Lv, Yufang Hou, Rixin Zhang, Weiqi Wang, Zheng Yan, Tiegang Li, Wenqiang Gan, Zifan Zeng, Fang Zhang, Min Yang*. Frontiers in Immunology. 2022. (IF: 8.786)
[4] Comprehensive analysis of a cancer-immunity cycle–based signature forpredicting prognosis and immunotherapyresponse in patients with colorectal cancer. Yufang Hou, Rixin Zhang, Jinbao Zong, Weiqi Wang, Mingxuan Zhou, Zheng Yan, Tiegang Li, Wenqiang Gan, Silin Lv, Zifan Zeng, Min Yang*. Frontiers in Immunology. 2022. (IF: 8.786)
[5] Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy. Tiegang Li, Weiqi Wang, Wenqiang Gan, Silin Lv, Zifan Zeng, Yufang Hou, Zheng Yan, Rixin Zhang, Min Yang*. Aging-US. 2022. (IF: 5.955)
[6] Prognostic values and underlying regulatory network of Cohesin subunits in esophageal carcinoma. Wenqiang Gan, Weiqi Wang, Tiegang Li, Rixin Zhang, Yufang Hou, Silin Lv, Zifan Zeng, Zheng Yan, Min Yang*. Journal of Cancer. 2022. (IF: 4.478)
[7] Lp-PLA2 inhibition prevents Ang II–induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation. Silin Lv, Zifan Zeng, Wenqiang Gan, Weiqi Wang, Tiegang Li, Yufang Hou, Zheng Yan, Rixin Zhang, Min Yang*. Acta Pharmacologica Sinica. 2021. (IF:7.169)
[8] SEMA6B overexpression predicts poor prognosis and correlates with the tumor immunosuppressive microenvironment in colorectal cancer. Tiegang Li#, Zheng Yan#, Weiqi Wang, Rixin Zhang, Wenqiang Gan, Silin Lv, Zifan Zeng, Yufang Hou, Min Yang*. Frontiers in Molecular Biosciences. 2021. (IF: 6.113)
[9] High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma. Yufang Hou#, Weiqi Wang#, Zifan Zeng#, Wenqiang Gan, Silin Lv, Tiegang Li, Zheng Yan, Rixin Zhang, Min Yang*. Aging-US. 2020. (IF: 5.682)
[10] Indoleamine 2, 3-dioxygenase 1 (IDO1) and CD8 expression profiling revealed an immunological subtype of colon cancer with a poor prognosis. Rixin Zhang, Tiegang Li, Weiqi Wang, Wenqiang Gan, Silin Lv, Zifan Zeng, Yufang Hou, Zheng Yan, Min Yang*. Frontiers in Oncology. 2020. (IF: 6.244)
[11] A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019. Weiqi Wang, Silin Lv, Wenqiang Gan, Zifan Zeng, Min Yang*. Annals of Translational Medicine. 2020. (IF: 3.932)
[12] Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma. Yufang Hou, Tiegang Li, Wenqiang Gan, Silin Lv, Zifan Zeng, Zheng Yan, Weiqi Wang, Min Yang*. Annals of Translational Medicine. 2020. (IF: 3.932)
[13] The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation. Wenqiang Gan#, Jingyuan Ren#, Tiegang Li, Silin Lv, Chenghe Li, Ziliang Liu, Min Yang*. Biochimica et Biophysica Acta-Molecular Basis of Disease. 2018. (IF: 4.328)
[14] Serum-glucocorticoid-regulated kinase 1 contributes to mechanical stretch-induced inflammatory responses in cardiac fibroblasts. Wenqiang Gan#, Tiegang Li#, Jingyuan Ren, Chenghe Li, Ziliang Liu, Min Yang*. Molecular and Cellular Biochemistry. 2018. (IF: 2.884)